European Commission 12 December 2008, Commission Decision of 12/12/2008 declaring a concentration to be compatible with the common market (Case No COMP/M.01) - SANTANDER / LASG / DCS) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)

27.1.2009 EN Official Journal of the European Union C 20/9 Non-opposition to a notified concentration (Case COMP/M.5393 — Teijin Pharma/Laboratorios del Dr. Esteve/Oximeplus) (Text with EEA relevance) (2009/C 20/05) On 7 January 2009, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market.